Global Veterinary Anti-infectives Market
Veterinary Healthcare

Veterinary Anti-infectives Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary anti-infectives market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Veterinary Anti-infectives Market And What Value Is Projected For 2029?

The veterinary anti-infectives sector has experienced significant expansion lately, with its market valuation projected to climb from $5.54 billion in 2024 to $6.02 billion by 2025, reflecting an 8.6% compound annual growth rate over that timeframe; this robust upward trend throughout the historical period is underpinned by several factors, including a larger population of pets, the rising incidence of various infectious ailments, strides made in veterinary medical science, heightened public understanding of animal health, and supportive governmental programs.

Projected for considerable expansion, the global market for veterinary anti-infectives is anticipated to reach a valuation of $8.69 billion by the year 2029, reflecting a sustained compound annual growth rate (CAGR) of 9.6% throughout the planning horizon; this upward trajectory is fueled by several key factors, such as the persistent rise in the number of companion animals, the emergence of diseases transmissible between animals and humans, the widening scope of international pet commerce, and the escalating spending dedicated to animal medical care, while notable shifts influencing this market include progress in technology, greater uptake of biologic treatments, the incorporation of remote consultation services into veterinary practice, a heightened interest in plant-derived and herbal remedies, the broadening reach of online sales for animal health drugs, and the formation of strategic alliances across the industry.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

What Factors Are Boosting The Veterinary Anti-infectives Market?

Future expansion within the veterinary anti-infectives sector is anticipated to be driven by a rise in the number of people who own pets, which includes keeping domestic animals like cats or dogs at home. A growing segment of the younger demographic views these animals as integral family members, while others procure them due to feelings of affection, the animals’ devoted nature, or as a defense against solitude. Demonstrating this trend, data from Animal Medicines Australia, an Australian non-profit group, indicated that pet ownership in Australia experienced substantial growth in 2022; the count of pet owners climbed to 28,730.8 that year, a considerable jump from the 39% figure reported in 2021, signifying a notable twenty-four percent escalation and pointing towards a robust pattern of increased pet acquisition and related healthcare expenditure. Consequently, this escalating prevalence of pet ownership directly fuels the need for veterinary anti-infective products.

What Are The Core Segmentation Criteria In The Veterinary Anti-infectives Market?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Which Emerging Trends Are Reshaping The Veterinary Anti-infectives Market Landscape?

A prominent movement within the sphere of veterinary anti-infectives involves the increasing adoption of cutting-edge technological progress, prompting key industry players to leverage sophisticated innovations to secure and enhance their standing. Illustratively, in February of 2022, Elanco Animal Health Incorporated, a US entity specializing in producing medicines and vaccines for companion and farm animals, introduced Increxxa, a recently authorized medication aimed at addressing respiratory illnesses in livestock. Containing tulathromycin as its core component, Increxxa is administered via injection to the animals, where it rapidly concentrates in the infected lung tissue, enabling swift therapeutic effect and a prolonged half-life, thereby affording cattle a greater window to build robustness against disease; this veterinarian-prescribed product utilizes tulathromycin to mitigate the adverse consequences associated with bovine respiratory disease.

Which Players Are Shaping The Competitive Landscape Of The Veterinary Anti-infectivesXX Market?

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What Regional Trends Are Shaping Growth In The Veterinary Anti-infectives Market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Browse Through More Reports Similar to the Global Veterinary Anti-infectives Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model